Full name
DANFARM MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.21.Z - General medical practice activities
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
68.20.Z - Rental and operating of own or leased real estate
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.D - Paramedical activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | 0,2 | 0,3 | 36,7 |
EBITDA | 0,5 | 0,3 | 0,4 | 32,2 |
Short time liabilities | 0,2 | 0,6 | 0,8 | 25,9 |
Equity capital | 0,6 | 0,8 | 1 | 33,4 |
Operating profit (EBIT) | 0,4 | 0,3 | 0,4 | 38,2 |
Assets | 0,9 | 1,9 | 2,4 | 28,5 |
Net profit (loss) | 0,4 | 0,2 | 0,3 | 38,1 |
Cash | 0,2 | 0,2 | 0,1 | -60,5 |
Net income from sale | 2,1 | 2,7 | 3,7 | 38 |
Liabilities and provisions for liabilities | 0,3 | 1,1 | 1,4 | 25 |
Working assets | 0,7 | 0,7 | 0,9 | 22,2 |
Depreciation | 0 | 0 | 0 | -2,9 |
% | % | % | p.p. | |
Profitability of capital | 65,4 | 25,2 | 26,1 | 0,9 |
Equity capital to total assets | 63,9 | 40,7 | 42,3 | 1,6 |
Gross profit margin | 19,9 | 8,2 | 8,1 | -0,1 |
EBITDA Margin | 21,7 | 12,4 | 11,9 | -0,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 33 | 86 | 79 | -7 |
Current financial liquidity indicator | 3.571331024169922 | 1.0734306573867798 | 1.1280972957611084 | 0 |
Net dept to EBITDA | 0.034813787788152695 | 1.9710382223129272 | 2.121436357498169 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane